2026 Recipients
Adam Scott
Adam Scott | Biomedical Engineering
Co-Founder & COO, Compact Medical Inc.
Adam Scott has dedicated the last 10 years to improving what has been the standard of care in CPR administration for decades: the bag-valve-mask (BVM) concept, dubbed the “Ambu Bag.” He and his partner, Dr. Jonathan Merrell, co-founded Compact Medical Inc. in 2016 and invented the world’s first FDA-cleared, 3-in-1 device — the ButterflyBVM. In experimental scenarios, patients are at risk of being hyperventilated more than 80% of the time, posing extreme risks like pneumothorax and constricted blood flow to the heart. “[The current standard of care does] not have controls in place to prevent users from over-bagging the patient. I would argue that [the devices] go so far as to enable it,” Scott said.
The ButterflyBVM, designed to remove the guessing game, touts adjustable volume, adjustable blow-off pressure and built-in rate control in a single, compact device. An early study showed that when compared to the Ambu Bag, the ButterflyBVM could decrease hyperventilation by 87%. Compact Medical began selling the device in November 2025 through three distributors, and within four minutes of going live, had to enact a waitlist. By the end of August 2026, the company had established 500+ agencies (fire, emergency, medical services, private ambulance services, education centers, hospitals, etc.) in the United States. Only on the market a short time, sales have exploded, with projections to sell and between 50,000 and 150,000 units in 2027. Lives have already been saved, and feedback from practitioners has been overwhelmingly positive. “This is what we live for in our work. It often means that Grandma, Mom, or Dad can be home for another Christmas,” Scott said.